Medically Reviewed By
Dr. Aditya Singh, MBBS, MD (Pharmacology)
Reg No: MCI-654321 • Verified Medical Reviewer
Ferriprox
(deferiprone)
Uses, side effects, dosage information & price range
About this medicine
Ferriprox monotherapy is indicated for the treatment of iron overload in patients with thalassaemia major when current chelation therapy is contraindicated or inadequate. Ferriprox in combination with another chelator is indicated in patients with thalassaemia major when monotherapy with any iron chelator is ineffective, or when prevention or treatment of life-threatening consequences of iron overload (mainly cardiac overload) justifies rapid or intensive correction.
Common Brand Names for this Composition
The following popular commercial brand names contain deferiprone as their active ingredient composition:
Kelfer 500 Capsule
Cipla Ltd
Kelfer 250 Capsule
Cipla Ltd
Ferriprox
Chiesi Farmaceutici S.p.A.
Deferiprone Lipomed
Lipomed GmbH
Upkanz
Apotex B.V.
Common Substitutes & Alternatives
These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.
Key Information
Salt / Composition
deferiprone
Category
All other therapeutic products
Manufacturer
Chiesi Farmaceutici S.p.A.
Medical Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.
Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.